What is a CVD?
As companies try to keep abreast of global pricing and reimbursement challenges, the product Core Value Dossier (CVD) has become an essential tool.
Incorporating key value arguments supporting their products, Core Value Dossiers allow commercial and development teams to develop integrated global market access strategies, achieving maximum product uptake across markets.
Core Value Dossiers act as a primary source of information for P&R negotiations and/or HTA submissions. They provide an understanding of a product’s value story and communicate the internal pricing and reimbursement (P&R) objectives and strategy across affiliates.
Core Value Dossier deliverable.
Good communication should be at the heart of every Core Value Dossier – the end user needs to find the information they need easily and as quickly as possible. With this in mind, our documents use clear structuring, good flow and hyperlinking to facilitate ease-of-use.
An Abacus CVD is presented as a layered communication. Product value messages contained in the Exec Summary or Value story will have key segments of text hyperlinked to the supporting evidence later in the document. Hyperlinked text will be shaded a different colour to allow the user to recognise a ‘live’ link.
In this manner, the Abacus Value Dossier allows the user to drill down to the information they need; from the value story, to the supporting body text, to the source reference.
Why choose an Abacus CVD?
With over 10 years experience in HTA writing, developing key messages based on best-available evidence is second nature to us. We research our topics thoroughly, and use only primary references to support value statements and therapeutic claims.
In-house health economics expertise
Cost-effectiveness and budget impact estimates have now become central to market access activities globally. As experts in this field, our in-house health economics team is best placed to develop value messages for both clinical and cost factors, providing an integrated evidence-based value story. We will advise on how best to present your economic data or work with you to develop de novo cost arguments.
Evidence-based value stories
Evidence-based medicine is central to reimbursement applications and HTA submissions worldwide – new products must prove their clinical and cost benefits in comparison to current therapy.
Full service offering
Abacus provides services at every stage of the product lifecycle. In addition to producing a Core Value Dossier, we can also develop cost-effectiveness models, conduct systematic reviews, prepare for HTA submissions, and develop commercial multimedia tools to support your product.
Commissioning Abacus for multiple activities allows us to become an integral part of your brand team, working with you to achieve an effective and integrated market access strategy.
